6505--Bevacizumab

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36E79720R0038
Agency
National Acquisition Center Headquarters, Department of Veterans Affairs
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Place of performance
USA

Notice details come from SAM.gov. Updated .

About this opportunity

This notice is for Request for Proposal 36E79720R0038 to establish a contract for the drug Bevacizumab for the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract period will be one base year plus four option years. Offerors must provide the exact drug name as it appears on the label and a unique NDC number. The solicitation will be issued electronically on May 21, 2020, with proposals due by June 4, 2020. The NAICS code is 325412 for this procurement.

There is no set-aside designation specified. The NAICS code is 325412 for Pharmaceutical Preparation Manufacturing. The contract items will be distributed through the VA and DOD Pharmaceutical Prime Vendor programs. The place of performance will be within the United States. Interested parties should monitor the identified website for any amendments leading up to the June 4th deadline.

Notice text

PRE-SOLICITATION NOTICE:  The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0038 for an unrestrictive procurement Bevacizumab, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS).  The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items.  The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA’s and DOD’s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number.  Solicitation #36E79720R0038 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 21st, 2020, with a tentative closing date of June 4th, 2020.  The NAICS code for this procurement is 325412.  Any future amendments and other miscellaneous documents will be available electronically for download on Contract Opportunities at the following URL: https://beta.sam.gov/search?index=opp.  No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation.  All responsible sources may submit an offer that if timely received, will be considered.  The point of contact for this procurement is Stevan Vasich. Questions can be e-mailed to: Stevan.Vasich@.gov.

Attachments

Files attached to this notice, newest first
File Type Posted
36E79720R0038.docx DOCX document

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
6505--Zirabev (bevacizumab-bvzr) Effective 8/13/2020 - 8/12/2021 Award Award Notice
6505--Bevacizumab This notice · Latest solicitation Solicitation
6505--Bevacizumab Original Pre-Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity